Comparison between2 Drugs in Lupus Nephritis

• Status: Not yet recruiting
• Trial end date: 2022-01-09
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this work is to study the effect and side effects of the cyclophosphamide versus mycophenolate in lupus nephritis

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Al-Azhar University
• Treatments: Cyclophosphamide; Dimethoate

Criteria

Inclusion Criteria:

1. All patients have systemic lupus erythromatosis with lupus nephritis either newly diagnosed or with history of SLE with lupus nephrits

2. All stage of lupus nephritis except stage(i,v,vi)

3. patients who accepted to participate in the study.

Exclusion Criteria:

1. Patient with acute inflammatory process such as(rheumatoid arthritis or other rhumatoligical diseases).

2. Patients who are taking other immunosuppressive therapy.

3. Patients with malignancies.

4. Patients with HCV, HBV or HIV infection.

5. Patients with lupus nephritis sage(i,v,vi).